Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting nerve repair via the TLR4/NF-κB pathway

CNS Neurosci Ther. 2023 Apr;29(4):1000-1011. doi: 10.1111/cns.14060. Epub 2023 Jan 4.

Abstract

Introduction: Sciatica causes intense pain. No satisfactory therapeutic drugs exist to treat sciatica. This study aimed to probe the potential mechanism of ferulic acid in sciatica treatment.

Methods: Thirty-two SD rats were randomly divided into 4 groups: sham operation, chronic constriction injury (CCI), mecobalamin, and ferulic acid. We conducted RNA sequencing, behavioral tests, ELISA, PCR, western blotting, and immunofluorescence analysis. TAK-242 and JSH23 were administered to RSC96 and GMI-R1 cells to explore whether ferulic acid can inhibit apoptosis and alleviate inflammation.

Results: RNA sequencing showed that TLR4/NF-κB pathway is involved in the mechanism of sciatica. CCI induced cold and mechanical hyperalgesia; destroyed the sciatic nerve structure; increased IL-1β, IL-6, TNF-α, IL-8, and TGF-β protein levels and IL-1β, IL-6, TNF-α, TGF-β, TLR4, and IBA-1 mRNA levels; and decreased IL-10 and INF-γ protein levels and IL-4 mRNA levels. Immunohistochemistry showed that IBA-1, CD32, IL-1β, iNOS, nNOS, COX2, and TLR4 expression was increased while S100β and Arg-1 decreased. CCI increased TLR4, IBA-1, IL-1β, iNOS, Myd88, p-NF-κB, and p-p38MAPK protein levels. Treatment with mecobalamin and ferulic acid reversed these trends. Lipopolysaccharide (LPS) induced RSC96 cell apoptosis by reducing Bcl-2 and Bcl-xl protein and mRNA levels and increasing Bax and Bad mRNA and IL-1β, TLR4, Myd88, p-NF-κB, and p-p38MAPK protein levels, while ferulic acid inhibited cell apoptosis by decreasing IL-1β, TLR4, Myd88, p-NF-κB, and p-p38MAPK levels and increasing Bcl-2 and Bcl-xl levels. In GMI-R1 cells, Ferulic acid attenuated LPS-induced M1 polarization by decreasing the M1 polarization markers IL-1β, IL-6, iNOS, and CD32 and increasing the M2 polarization markers CD206, IL-4, IL-10 and Arg-1. After LPS treatment, IL-1β, iNOS, TLR4, Myd88, p-p38MAPK, and p-NF-κB levels were obviously increased, and Arg-1 expression was reduced, while ferulic acid reversed these changes.

Conclusion: Ferulic acid can promote injured sciatic nerve repair by reducing neuronal cell apoptosis and inflammatory infiltration though the TLR4/NF-κB pathway.

Keywords: CCI; GMI-R1; NF-κB; RSC96; TLR4; ferulic acid; inflammation; pain; sciatica.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Coumaric Acids* / pharmacology
  • Coumaric Acids* / therapeutic use
  • Interleukin-10 / metabolism
  • Interleukin-4 / metabolism
  • Interleukin-6 / metabolism
  • Lipopolysaccharides / toxicity
  • Myeloid Differentiation Factor 88 / metabolism
  • NF-kappa B* / metabolism
  • Neuroinflammatory Diseases / drug therapy
  • Neuroinflammatory Diseases / metabolism
  • RNA, Messenger
  • Rats
  • Rats, Sprague-Dawley
  • Sciatica* / drug therapy
  • Sciatica* / metabolism
  • Signal Transduction
  • Toll-Like Receptor 4* / metabolism
  • Transforming Growth Factor beta / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • ferulic acid
  • Interleukin-10
  • Interleukin-4
  • Interleukin-6
  • Lipopolysaccharides
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • RNA, Messenger
  • Tlr4 protein, rat
  • Toll-Like Receptor 4
  • Transforming Growth Factor beta
  • Tumor Necrosis Factor-alpha
  • Coumaric Acids